{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:29:41Z","timestamp":1789662581195,"version":"4.0.1"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,14]],"date-time":"2018-01-14T00:00:00Z","timestamp":1515888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jacbts.2018.01.003","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T02:16:17Z","timestamp":1527646577000},"page":"313-326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Cardiovascular Precision Medicine in the Genomics Era"],"prefix":"10.1016","volume":"3","author":[{"given":"Alexandra M.","family":"Dainis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euan A.","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2018.01.003_bib1","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1007\/s002800100310","article-title":"STI571, a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia: validating the promise of molecularly targeted therapy","volume":"48","author":"Mauro","year":"2001","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jacbts.2018.01.003_bib2","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/S1470-2045(15)00620-8","article-title":"Precision oncology: origins, optimism, and potential","volume":"17","author":"Prasad","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jacbts.2018.01.003_bib3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1634\/theoncologist.2008-0230","article-title":"The HER-2 receptor and breast cancer: ten years of targeted anti\u2013HER-2 therapy and personalized medicine","volume":"14","author":"Ross","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.jacbts.2018.01.003_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/bs.acc.2015.03.006","article-title":"Chapter Three-monitoring trastuzumab resistance and cardiotoxicity: a tale of personalized medicine","volume":"70","author":"Dokmanovic","year":"2015","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.jacbts.2018.01.003_bib5","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/cts.12292","article-title":"Precision genomic medicine in cystic fibrosis","volume":"8","author":"Chang","year":"2015","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jacbts.2018.01.003_bib6","article-title":"Transitioning from usual care to biomarker-based personalized and precision medicine in heart failure: call for action","author":"Bayes-Genis","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2018.01.003_bib7","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(10)60452-7","article-title":"Clinical assessment incorporating a personal genome","volume":"375","author":"Ashley","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacbts.2018.01.003_bib8","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/europace\/eur245","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"13","author":"Ackerman","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.jacbts.2018.01.003_bib9","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1016\/j.jacc.2011.10.825","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"58","author":"Gersh","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jacbts.2018.01.003_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001221","article-title":"Delivering clinical grade sequencing and genetic test interpretation for cardiovascular medicine","volume":"10","author":"Harper","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacbts.2018.01.003_bib11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/gim.2016.90","article-title":"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples","volume":"19","author":"Walsh","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.jacbts.2018.01.003_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/HCO.0b013e32835fb728","article-title":"Genetic testing in cardiovascular medicine: current landscape and future horizons","volume":"28","author":"Sturm","year":"2013","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.jacbts.2018.01.003_bib13","series-title":"IOC Manual of Sports Cardiology","first-page":"175","article-title":"Genetic testing for cardiovascular conditions predisposing to sudden death","author":"Caleshu","year":"2016"},{"key":"10.1016\/j.jacbts.2018.01.003_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13506129.2017.1374946","article-title":"Safety and efficacy of a TTR specific antisense oligonucleotide in patients with transthyretin amyloid cardiomyopathy","volume":"24","author":"Benson","year":"2017","journal-title":"Amyloid"},{"key":"10.1016\/j.jacbts.2018.01.003_bib15","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/CIRCULATIONAHA.116.024258","article-title":"Next-generation sequencing in cardiovascular disease: present clinical applications and the horizon of precision medicine","volume":"135","author":"Parikh","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2018.01.003_bib16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/jama.2017.8543","article-title":"Cascade screening for familial hypercholesterolemia and the use of genetic testing","volume":"318","author":"Knowles","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jacbts.2018.01.003_bib17","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/eurheartj\/ehx111","article-title":"Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK","volume":"38","author":"Kerr","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2018.01.003_bib18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/heartjnl-2011-300368","article-title":"A\u00a0cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy","volume":"98","author":"Ingles","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.jacbts.2018.01.003_bib19","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/eurheartj\/ehq067","article-title":"DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model","volume":"31","author":"Wordsworth","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2018.01.003_bib20","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.hrthm.2005.08.026","article-title":"Cost-effectiveness analysis of genetic testing for familial long QT syndrome in symptomatic index cases","volume":"2","author":"Phillips","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacbts.2018.01.003_bib21","first-page":"359","article-title":"Molecular autopsy in victims of inherited arrhythmias","volume":"32","author":"Semsarian","year":"2016","journal-title":"J\u00a0Arrhythm"},{"key":"10.1016\/j.jacbts.2018.01.003_bib22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.5694\/j.1326-5377.2008.tb02173.x","article-title":"Reducing sudden death in young people in Australia and New Zealand: the TRAGADY initiative","volume":"189","author":"Skinner","year":"2008","journal-title":"Med J Aust"},{"key":"10.1016\/j.jacbts.2018.01.003_bib23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cpcardiol.2013.08.001","article-title":"Genotype- and phenotype-guided management of congenital long QT syndrome","volume":"38","author":"Giudicessi","year":"2013","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.jacbts.2018.01.003_bib24","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jacc.2015.12.033","article-title":"Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3","volume":"67","author":"Mazzanti","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2018.01.003_bib25","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jacc.2014.05.068","article-title":"Efficacy of different beta-blockers in the treatment of long QT syndrome","volume":"64","author":"Abu-Zeitone","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2018.01.003_bib26","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.hrthm.2014.06.030","article-title":"Molecular diagnosis of long QT syndrome at 10 days of life by rapid whole genome sequencing","volume":"11","author":"Priest","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacbts.2018.01.003_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1161\/CIRCRESAHA.116.310216","article-title":"Calming down arrhythmogenic calmodulinopathies via a precision medicine approach","volume":"120","author":"Bers","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2018.01.003_bib28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.hrthm.2014.11.017","article-title":"Calmodulinopathy: a genetic trilogy","volume":"12","author":"George","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacbts.2018.01.003_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.yjmcc.2014.04.022","article-title":"Calmodulin mutations associated with long QT syndrome prevent inactivation of cardiac L-type Ca(2+) currents and promote proarrhythmic behavior in ventricular myocytes","volume":"74","author":"Limpitikul","year":"2014","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2018.01.003_bib30","article-title":"Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms","volume":"3","author":"Yin","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2018.01.003_bib31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCRESAHA.116.309283","article-title":"A\u00a0precision medicine approach to the rescue of function on malignant calmodulinopathic long QT syndrome","volume":"120","author":"Limpitikul","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2018.01.003_bib32","first-page":"218388","article-title":"Genome-wide polygenic score to identify a monogenic risk-equivalent for coronary disease","author":"Khera","year":"2017","journal-title":"bioRxiv"},{"key":"10.1016\/j.jacbts.2018.01.003_bib33","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1001\/jama.302.21.2388","article-title":"Coronary heart disease risk factors","volume":"302","author":"Torpy","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacbts.2018.01.003_bib34","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/CIRCULATIONAHA.115.020109","article-title":"Incorporating a genetic risk score into coronary heart disease risk estimates: effect on low-density lipoprotein cholesterol levels (the MI-GENES Clinical Trial)","volume":"133","author":"Kullo","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2018.01.003_bib35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2261-11-66","article-title":"Genotype-informed estimation of risk of coronary heart disease based on genome-wide association data linked to the electronic medical record","volume":"11","author":"Ding","year":"2011","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacbts.2018.01.003_bib36","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/CIRCULATIONAHA.116.021765","article-title":"Reducing cardiovascular risk using genomic information in the era of precision medicine","volume":"133","author":"Natarajan","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2018.01.003_bib37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/cge.12577","article-title":"Disclosing genetic risk for coronary heart disease: effects on perceived personal control and genetic counseling satisfaction","volume":"89","author":"Robinson","year":"2016","journal-title":"Clin Genet"},{"issue":"4","key":"10.1016\/j.jacbts.2018.01.003_bib38","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001613","article-title":"Effect of disclosing genetic risk for coronary heart disease on information seeking and sharing: The MI-GENES Study (Myocardial Infarction Genes)","volume":"10","author":"Brown","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacbts.2018.01.003_bib39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fcvm.2017.00053","article-title":"Impact of a genetic risk score for coronary artery disease on reducing cardiovascular risk: a pilot randomized controlled study","volume":"4","author":"Knowles","year":"2017","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacbts.2018.01.003_bib40","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/S0140-6736(14)61730-X","article-title":"Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials","volume":"385","author":"Mega","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacbts.2018.01.003_bib41","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/CIRCULATIONAHA.116.024436","article-title":"Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting: clinical perspective","volume":"135","author":"Natarajan","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2018.01.003_bib42","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMoa1605086","article-title":"Genetic risk, adherence to a healthy lifestyle, and coronary disease","volume":"375","author":"Khera","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2018.01.003_bib43","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.mayocp.2017.01.015","article-title":"Precision cardiovascular medicine: state of genetic testing","volume":"92","author":"Giudicessi","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacbts.2018.01.003_bib44","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","article-title":"The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association","volume":"132","author":"Gidding","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2018.01.003_bib45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tibs.2006.12.008","article-title":"Molecular biology of PCSK9: its role in LDL metabolism","volume":"32","author":"Horton","year":"2007","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jacbts.2018.01.003_bib46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng1509","article-title":"Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9","volume":"37","author":"Cohen","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacbts.2018.01.003_bib47","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2018.01.003_bib48","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1126\/science.1125884","article-title":"Biomedicine. Lowering LDL\u2014not only how low, but how long?","volume":"311","author":"Brown","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jacbts.2018.01.003_bib49","series-title":"PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews","author":"Schmidt","year":"2017"},{"key":"10.1016\/j.jacbts.2018.01.003_bib50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1609243","article-title":"A\u00a0highly durable RNAi therapeutic inhibitor of PCSK9","volume":"376","author":"Fitzgerald","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2018.01.003_bib51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/clc.22713","article-title":"PCSK9 inhibitor access barriers-issues and recommendations: improving the access process for patients, clinicians and payers","volume":"40","author":"Baum","year":"2017","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacbts.2018.01.003_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1602814","article-title":"CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice","volume":"3","author":"Zhang","year":"2017","journal-title":"Sci Adv"},{"key":"10.1016\/j.jacbts.2018.01.003_bib53","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/gt.2009.153","article-title":"Electroporation-mediated delivery of a naked DNA plasmid expressing VEGF to the porcine heart enhances protein expression","volume":"17","author":"Marshall","year":"2009","journal-title":"Gene Ther"},{"key":"10.1016\/j.jacbts.2018.01.003_bib54","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/CIRCRESAHA.117.310882","article-title":"Allele specific silencing of mutant mRNA rescues ultrastructural and arrhythmic phenotype in mice carriers of the R4496C mutation in the ryanodine receptor gene (RYR2)","volume":"121","author":"Bongianino","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2018.01.003_bib55","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1161\/01.CIR.100.5.468","article-title":"Angiogenesis gene therapy","volume":"100","author":"Rosengart","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2018.01.003_bib56","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jconrel.2014.07.041","article-title":"Functional polymers of gene delivery for treatment of myocardial infarct","volume":"195","author":"Won","year":"2014","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.jacbts.2018.01.003_bib57","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/CIRCRESAHA.115.304351","article-title":"Permanent alteration of PCSK9 with in\u00a0vivo CRISPR-Cas9 genome editing","volume":"115","author":"Ding","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2018.01.003_bib58","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature23305","article-title":"Correction of a pathogenic gene mutation in human embryos","volume":"548","author":"Ma","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jacbts.2018.01.003_bib59","first-page":"181255","article-title":"Inter-homologue repair in fertilized human eggs?","author":"Egli","year":"2017","journal-title":"bioRxiv"},{"key":"10.1016\/j.jacbts.2018.01.003_bib60","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10815-009-9334-6","article-title":"Fish based preimplantation genetic diagnosis to prevent DiGeorge syndrome","volume":"26","author":"Shefi","year":"2009","journal-title":"J\u00a0Assist Reprod Genet"},{"key":"10.1016\/j.jacbts.2018.01.003_bib61","first-page":"542961","article-title":"Preimplantation genetic diagnosis in Marfan syndrome","volume":"2013","author":"Vlahos","year":"2013","journal-title":"Case Rep Obstet Gynecol"},{"key":"10.1016\/j.jacbts.2018.01.003_bib62","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/ejhg.2009.56","article-title":"Preimplantation genetic diagnosis for myotonic dystrophy type 1: upon request to child","volume":"17","author":"De Rademaeker","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jacbts.2018.01.003_bib63","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMp1710370","article-title":"Compelling reasons for repairing human germlines","volume":"377","author":"Church","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2018.01.003_bib64","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jacbts.2018.01.003_bib65","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2012.10.010","article-title":"Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells","volume":"12","author":"Lan","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"377","key":"10.1016\/j.jacbts.2018.01.003_bib66","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf2584","article-title":"High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells","volume":"9","author":"Sharma","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jacbts.2018.01.003_bib67","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.celrep.2014.09.055","article-title":"Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells","volume":"9","author":"Drawnel","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.jacbts.2018.01.003_bib68","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCRESAHA.117.305365","article-title":"Human induced pluripotent stem cell\u2013derived cardiomyocytes","volume":"117","author":"Karakikes","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2018.01.003_bib69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.trsl.2015.09.008","article-title":"Advances in therapeutic CRISPR\/Cas9 genome editing","volume":"168","author":"Savi\u0107","year":"2016","journal-title":"Transl Res"},{"key":"10.1016\/j.jacbts.2018.01.003_bib70","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1101\/gr.173427.114","article-title":"Seamless gene correction of \u03b2-thalassemia mutations in patient-specific iPSCs using CRISPR\/Cas9 and piggyBac","volume":"24","author":"Xie","year":"2014","journal-title":"Genome Res"},{"key":"10.1016\/j.jacbts.2018.01.003_bib71","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.ackd.2015.12.001","article-title":"Cardiovascular pharmacogenomics\u2014implications for patients with CKD","volume":"23","author":"Cavallari","year":"2016","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.jacbts.2018.01.003_bib72","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMoa1311386","article-title":"A\u00a0randomized trial of genotype-guided dosing of warfarin","volume":"369","author":"Pirmohamed","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2018.01.003_bib73","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa1310669","article-title":"A\u00a0pharmacogenetic versus a clinical algorithm for\u00a0warfarin dosing","volume":"369","author":"Kimmel","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2018.01.003_bib74","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/jama.2017.11469","article-title":"Effect of genotype-guided warfarin dosing on clinical events and anticoagulation control among patients undergoing hip or knee arthroplasty: The GIFT randomized clinical trial","volume":"318","author":"Gage","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jacbts.2018.01.003_bib75","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jama.2017.11465","article-title":"Pharmacogenomic testing and warfarin: what evidence has the GIFT trial provided?","volume":"318","author":"Emery","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jacbts.2018.01.003_bib76","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/phar.1982","article-title":"Warfarin pharmacogenomics in diverse populations","volume":"37","author":"Kaye","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jacbts.2018.01.003_bib77","doi-asserted-by":"crossref","first-page":"D865","DOI":"10.1093\/nar\/gkw1039","article-title":"The human phenotype ontology in 2017","volume":"45","author":"K\u00f6hler","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jacbts.2018.01.003_bib78","article-title":"Genetic analysis of deep phenotyping projects in common disorders","author":"Gershon","year":"2017","journal-title":"Schizophr Res"},{"key":"10.1016\/j.jacbts.2018.01.003_bib79","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jcmg.2017.07.001","article-title":"The potential of clinical phenotyping of heart failure with imaging biomarkers for guiding therapies: a focused update","volume":"10","author":"Sengupta","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacbts.2018.01.003_bib80","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMsa1507092","article-title":"Genetic misdiagnoses and the potential for health disparities","volume":"375","author":"Manrai","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2018.01.003_bib81","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrg.2017.89","article-title":"Prioritizing diversity in human genomics research","volume":"19","author":"Hindorff","year":"2018","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jacbts.2018.01.003_bib82","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/475163a","article-title":"Genomics for the world","volume":"475","author":"Bustamante","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jacbts.2018.01.003_bib83","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/ng.3700","article-title":"Prospective functional classification of all possible missense variants in PPARG","volume":"48","author":"Majithia","year":"2016","journal-title":"Nat Genet"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X18300081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X18300081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:19:11Z","timestamp":1762820351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X18300081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S2452302X18300081"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2018.01.003","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Precision Medicine in the Genomics Era","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2018.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}